National Apr 24, 2021

Japan approves third drug for COVID-19 treatment

The health ministry has approved the use of baricitinib, a rheumatoid drug, for treating COVID-19 patients, making it the third drug OK'd for use against the virus in the country after remdesivir and dexamethasone. Baricitinib, sold under the brand name Olumiant, is currently administered to ...